COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 425: Articles 4241-4250  | Next

Universal features of Nsp1-mediated translational shutdown by coronaviruses
Schubert, K., Karousis, E. D., Ban, I., Lapointe, C., Leibundgut, M., Baeumlin, E., Kummerant, E., Scaiola, A., Schoenhut, T., Ziegelmueller, J., Puglisi, J., Muehlemann, O., Ban, N.
10.1101/2023.05.31.543022 — Posted: 2023-06-01
Stroke Hospitalization Administration & Monitoring: Routine Or Covid-19 Care (SHAMROCC)
Langlois-Therien, T., Shamy, M., Dewar, B., Ramsay, T., Lun, R., Blacquiere, D., Dowlatshahi, D., Stotts, G., Fahed, R., Ducroux, C.
10.1101/2023.05.29.23290701 — Posted: 2023-05-31
Infection by SARS-CoV-2 with alternate frequencies of mRNA vaccine boosting for patients undergoing antineoplastic treatment for cancer
Townsend, J. P., Hassler, H., Emu, B., Dornburg, A.
10.1101/2023.05.25.23290402 — Posted: 2023-05-30
Incidence of SARS-CoV-2 infection and associated risk factors among staff and residents at homeless shelters in King County, Washington: an active surveillance study
Rogers, J. H., Cox, S. N., Link, A. C., Nwanne, G., Han, P. D. H., Pfau, B., Chow, E. J., Wolf, C., Boeckh, M., Hughes, J. P., Halloran, M. E., Uyeki, T. M., Shim, M. M., Duchin, J., Englund, J. A., Mosites, E., Rolfes, M., Starita, L. A., Chu, H. Y.
10.1101/2023.05.25.23290471 — Posted: 2023-05-30
Antibodies against SARS-CoV-2 control complement-induced inflammatory responses to SARS-CoV-2
Bermejo-Jambrina, M., van der Donk, L. E. H., van Hamme, J. L., Wilflingseder, D., de Bree, G., Prins, M., de Jong, M., Nieuwkerk, P., van Gils, M. J., Kootstra, N. A., Geijtenbeek, T.
10.1101/2023.05.29.542735 — Posted: 2023-05-30
Association between lifestyle factors and weight in Japan university students during COVID-19 mild lockdown: a quantitative study
Arimori, H., Abiru, N., Morimoto, S., Nishino, T., Kawakami, A., Kamada, A., Kobayashi, M.
10.1101/2023.05.24.23290491 — Posted: 2023-05-30
Effectiveness of BNT162b2 mRNA vaccine third doses and previous infection in protecting against SARS-CoV-2 infections during the Delta and Omicron variant waves; the UK SIREN cohort study September 2021 to February 2022
Hall, V. J., Insalata, F., Foulkes, S., Kirwan, P. D., Sparkes, D., Atti, A., Cole, M., de Lacy, E., Price, L., Corrigan, D., Brown, C. S., Islam, J., The SIREN Study Group, , Charlett, A., Hopkins, S.
10.1101/2023.05.22.23290197 — Posted: 2023-05-29
Identification of targets for drug repurposing to treat COVID-19 using a Deep Learning Neural Network
Wang, S. H., Tang, Y.-H., Hsu, H., Yu, C.-N., Lee, O. K.-S.
10.1101/2023.05.23.23290403 — Posted: 2023-05-29
Distinct and overlapping immunological responses to SARS-CoV-2 and Mycobacterium tuberculosis identified by single-cell RNA-seq of co-infected whole blood
Sheerin, D., Phan, T. K., Eriksson, E. M., COVID PROFILE Consortium, , Coussens, A. K.
10.1101/2023.05.24.23290499 — Posted: 2023-05-29
Development of a SARS-COV-2 monoclonal antibody panel and its applicability as a reagent in high-throughput fluorescence reduction neutralization and immunohistochemistry assays
Mattoso, G., Cataneo, A., Raboni, S. M., Nogueira, M. B., Vaz de Paula, C., Almeida, A. C., Rogerio, V., Zanchin, N., de Noronha, L., Zanluca, C., Duarte dos Santos, C. N.
10.1101/2023.05.29.542720 — Posted: 2023-05-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).